Search results for "Immunologic"

showing 10 items of 1115 documents

Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell–engrafted NOD/SCID/IL-2Rγcnull mice

2013

Current strategies in cellular immunotherapy of cancer and viral infections include the adoptive transfer of T cell receptor (TCR) and chimeric antigen receptor engineered T cells. When using transient RNA expression systems in clinical studies, multiple infusions with receptor-redirected T cells appear necessary. However, in allogeneic hematopoietic stem-cell transplantation, repeated transfer of donor-derived T cells increases the risk of alloreactive graft-versus-host disease. We investigated naive-derived (T N ), memory-derived (T M ), and Epstein Barr virus-specific (T EBV ) CD8 + T cell subsets for alloreactivity upon redirection with RNA encoding a cytomegalovirus-specific model TCR.…

Herpesvirus 4 HumanCancer ResearchT-LymphocytesT cellAntigens CD34Mice SCIDStreptamerCD8-Positive T-LymphocytesBiologyImmunotherapy AdoptiveMiceInterleukin 21GeneticsmedicineAnimalsHumansTransplantation HomologousCytotoxic T cellIL-2 receptorAntigen-presenting cellMolecular BiologyInterleukin 3Histocompatibility TestingHematopoietic Stem Cell TransplantationCell BiologyHematologyNatural killer T cellmedicine.anatomical_structureImmunologyCancer researchImmunologic MemoryInterleukin Receptor Common gamma SubunitExperimental Hematology
researchProduct

Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance

2002

CD8+ T cells are the main effector cells for the immune control of cytomegaloviruses. To subvert this control, human and mouse cytomegaloviruses each encode a set of immune-evasion proteins, referred to here as immunoevasins, which interfere specifically with the MHC class I pathway of antigen processing and presentation. Although the concerted action of immunoevasins prevents the presentation of certain viral peptides, other viral peptides escape this blockade conditionally or constitutively and thereby provide the molecular basis of immune surveillance by CD8+ T cells. The definition of viral antigenic peptides that are presented despite the presence of immunoevasins adds a further dimens…

HistorybiologyAntigen processingAntigen presentationImmunologic Surveillancechemical and pharmacologic phenomenamedicine.diseaseVirologyEpitopeComputer Science ApplicationsEducationAntigenMHC class IVirus latencyImmunologybiology.proteinmedicineCD8Nature Reviews Immunology
researchProduct

Development of novel vaccine strategies against human cytomegalovirus infection based on subviral particles.

2002

Abstract Background: Pre- and perinatal human cytomegalovirus (HCMV) infection remains one of the major causes of mental defects and sensineural hearing loss in children. In addition, it is a prominent infectious complication in immunosuppressed individuals such as AIDS patients or transplant recipients. Therefore, the development of an HCMV vaccine has been given top priority by health care institutions. Study design: Defective subviral particles of HCMV, termed Dense Bodies (DB) contain the dominant target antigens for humoral and cellular immune responses elicited during natural infection. These enveloped particles are released from infected culture cells and can be purified by gradient …

Human cytomegalovirusCytotoxicity ImmunologicImmunogenCytomegalovirusMice TransgenicBiologyAntibodies ViralVirusCell LineCytomegalovirus VaccinesMiceImmune systemAntigenNeutralization TestsVirologymedicineCytotoxic T cellAnimalsHumansMice Inbred BALB CVirionmedicine.diseaseVirologyCTL*Infectious DiseasesImmunizationVaccines InactivatedImmunologyCytomegalovirus InfectionsT-Lymphocytes CytotoxicJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology
researchProduct

Experimental Preemptive Immunotherapy of Murine Cytomegalovirus Disease with CD8 T-Cell Lines Specific for ppM83 and pM84, the Two Homologs of Human …

2001

ABSTRACTCD8 T cells are the principal antiviral effectors controlling cytomegalovirus (CMV) infection. For human CMV, the virion tegument protein ppUL83 (pp65) has been identified as a source of immunodominant peptides and is regarded as a candidate for cytoimmunotherapy and vaccination. Two sequence homologs of ppUL83 are known for murine CMV, namely the virion protein ppM83 (pp105) expressed late in the viral replication cycle and the nonstructural protein pM84 (p65) expressed in the early phase. Here we show that ppM83, unlike ppUL83, is not delivered into the antigen presentation pathway after virus penetration before or in absence of viral gene expression, while other virion proteins o…

Human cytomegalovirusMuromegalovirusmedicine.medical_treatmentImmunologyImmunodominanceCD8-Positive T-LymphocytesBiologyMicrobiologyCell LineViral Matrix ProteinsInterferon-gammaMiceImmune systemAntigenVirologyVaccines and Antiviral AgentsmedicineAnimalsCytotoxic T cellMice Inbred BALB CHerpesviridae InfectionsImmunotherapyPhosphoproteinsmedicine.diseaseAdoptive TransferVirologyPeptide FragmentsDisease Models AnimalViral replicationInsect ScienceImmunologyFemaleCytokine secretionImmunologic MemoryJournal of Virology
researchProduct

Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination.

2011

Cytomegalovirus (CMV) is frequently transmitted by solid organ transplantation and is associated with graft failure. By forming the boundary between circulation and organ parenchyma, endothelial cells (EC) are suited for bidirectional virus spread from and to the transplant. We applied Cre/loxP-mediated green-fluorescence-tagging of EC-derived murine CMV (MCMV) to quantify the role of infected EC in transplantation-associated CMV dissemination in the mouse model. Both EC- and non-EC-derived virus originating from infected Tie2-cre + heart and kidney transplants were readily transmitted to MCMV-naïve recipients by primary viremia. In contrast, when a Tie2-cre + transplant was infected by pri…

Human cytomegalovirusMuromegalovirusmedicine.medical_treatmentKidneyMicelcsh:QH301-705.5Kidney transplantationHeart transplantationbiologyvirus diseasesHeartAnimal ModelsHost-Pathogen InteractionInfectious Diseasessurgical procedures operativemedicine.anatomical_structureOncologyMedical MicrobiologyCytomegalovirus InfectionsMedicineResearch Articlelcsh:Immunologic diseases. AllergyEndotheliumImmunologyCongenital cytomegalovirus infection610ViremiaMice TransgenicMicrobiologyVirusModel OrganismsMuromegalovirusVirologyGeneticsmedicineAnimalsViremiaBiologyMolecular BiologyEndothelial Cellsmedicine.diseasebiology.organism_classificationVirologyKidney Transplantationlcsh:Biology (General)ImmunologyHeart TransplantationSurgeryParasitologyEndothelium Vascularlcsh:RC581-607PLoS pathogens
researchProduct

The viral chemokine MCK-2 of murine cytomegalovirus promotes infection as part of a gH/gL/MCK-2 complex.

2013

Human cytomegalovirus (HCMV) forms two gH/gL glycoprotein complexes, gH/gL/gO and gH/gL/pUL(128,130,131A), which determine the tropism, the entry pathways and the mode of spread of the virus. For murine cytomegalovirus (MCMV), which serves as a model for HCMV, a gH/gL/gO complex functionally homologous to the HCMV gH/gL/gO complex has been described. Knock-out of MCMV gO does impair, but not abolish, virus spread indicating that also MCMV might form an alternative gH/gL complex. Here, we show that the MCMV CC chemokine MCK-2 forms a complex with the glycoprotein gH, a complex which is incorporated into the virion. We could additionally show that mutants lacking both, gO and MCK-2 are not ab…

Human cytomegalovirusViral DiseasesMuromegalovirusChemokinevirusesMurine Cytomegalovirus ; viral chemokine MCK-2 ; gH/gL/MCK-2 complexMiceViral Envelope ProteinsBiology (General)Cells Culturedchemistry.chemical_classificationMice Inbred BALB Cvirus diseasesHerpesviridae InfectionsRecombinant ProteinsSpecific Pathogen-Free OrganismsInfectious DiseasesLiverChemokines CCMedicineFemaleResearch ArticleQH301-705.5ImmunologyBiologyMicrobiologyVirusCell LineViral ProteinsMuromegalovirusGlycoprotein complexVirologyGeneticsmedicineAnimalsBiologyMolecular BiologyTropismMacrophagesVirionVirus InternalizationRC581-607medicine.diseasebiology.organism_classificationVirologyImmunity InnatechemistryCell cultureMutationMacrophages Peritonealbiology.proteinParasitologyProtein MultimerizationImmunologic diseases. AllergyGlycoprotein
researchProduct

Identification of a Conserved HLA-A2-Restricted Decapeptide from the IE1 Protein (pUL123) of Human Cytomegalovirus

2002

Abstract Control of human cytomegalovirus (HCMV) infection is predominantly mediated by cytolytic CD8 + T lymphocytes (CTL). Among the roughly 200 HCMV-encoded polypeptides, the tegument protein pp65 (ppUL83) and the nonstructural IE1 protein are considered to be dominant CTL targets. Yet the importance of CTL against IE1 for protective immunity against HCMV reactivation and disease has remained elusive. Analyses have been difficult, as all MHC class I presented peptides of IE1 defined so far are located in parts of the protein that are variable between viral strains. In this study a conserved decameric peptide from IE1 (P6, IE1 354–363 ) that bound to HLA-A2 was identified. Using peptide-p…

Human cytomegalovirusherpesvirusesViral proteinvirusesMolecular Sequence DataIE1CytomegalovirusEpitopes T-Lymphocytecytotoxic T lymphocytesmedicine.disease_causeImmediate early proteinCell LineImmediate-Early ProteinsViral Proteinsconserved CTL epitopesVirologyHLA-A2 AntigenMHC class ImedicineHumansCytotoxic T cellAmino Acid SequenceConserved SequencebiologyELISPOTvirus diseasesHLA-A2biochemical phenomena metabolism and nutritionCytotoxicity Tests Immunologicmedicine.diseaseVirologyPeptide FragmentsVirus LatencyCTL*human cytomegalovirusCytomegalovirus InfectionsImmunologybiology.proteinPeptidesCD8T-Lymphocytes CytotoxicVirology
researchProduct

Non-redundant and redundant roles of cytomegalovirus gH/gL complexes in host organ entry and intra-tissue spread

2015

Herpesviruses form different gH/gL virion envelope glycoprotein complexes that serve as entry complexes for mediating viral cell-type tropism in vitro; their roles in vivo, however, remained speculative and can be addressed experimentally only in animal models. For murine cytomegalovirus two alternative gH/gL complexes, gH/gL/gO and gH/gL/MCK-2, have been identified. A limitation of studies on viral tropism in vivo has been the difficulty in distinguishing between infection initiation by viral entry into first-hit target cells and subsequent cell-to-cell spread within tissues. As a new strategy to dissect these two events, we used a gO-transcomplemented ΔgO mutant for providing the gH/gL/gO…

Human cytomegalovirusherpesvirusesvirusesgH/FL complexesCytomegalovirusMiceViral Envelope ProteinsMedizinische FakultätBiology (General)In Situ Hybridization0303 health sciencesMice Inbred BALB CMembrane GlycoproteinsImmunohistochemistrycytomegalovirus ; gH/FL complexes ; gO ; MCK-2 ; herpesvirusesCytomegalovirus InfectionsFemaleMCK-2BIOMEDICINA I ZDRAVSTVO. Temeljne medicinske znanosti.Research ArticleQH301-705.5Immunology-BiologyMicrobiologyVirus03 medical and health sciencesgOViral entryIn vivoVirologyGeneticsmedicineAnimalsddc:610Molecular BiologyTropism030304 developmental biology030306 microbiologyBIOMEDICINE AND HEALTHCARE. Basic Medical Sciences.RC581-607medicine.diseaseVirologyHerpesvirus glycoprotein BDisease Models AnimalViral TropismCell cultureTissue tropismParasitologyImmunologic diseases. Allergy
researchProduct

Evaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice

2015

Reactivation of human cytomegalovirus (HCMV) can cause severe disease in recipients of hematopoietic stem cell transplantation. Although preclinical research in murine models as well as clinical trials have provided 'proof of concept' for infection control by pre-emptive CD8 T-cell immunotherapy, there exists no predictive model to experimentally evaluate parameters that determine antiviral efficacy of human T cells in terms of virus control in functional organs, prevention of organ disease, and host survival benefit. We here introduce a novel mouse model for testing HCMV epitope-specific human T cells. The HCMV UL83/pp65-derived NLV-peptide was presented by transgenic HLA-A2.1 in the conte…

Human cytomegaloviruslcsh:Immunologic diseases. Allergymedicine.medical_treatmentT cellImmunologyCell- and Tissue-Based TherapyCytomegalovirusEpitopes T-LymphocyteMice TransgenicHematopoietic stem cell transplantationHuman leukocyte antigenMice SCIDBiologyMicrobiologyViral Matrix ProteinsMice Inbred NODVirologyHLA-A2 AntigenGeneticsmedicineCytotoxic T cellAnimalsHumansMolecular Biologylcsh:QH301-705.5ImmunotherapyViral Loadmedicine.diseaseMice Inbred C57BLDisease Models Animalmedicine.anatomical_structurelcsh:Biology (General)ImmunologyCytomegalovirus InfectionsParasitologylcsh:RC581-607Viral loadCD8Research ArticlePLoS Pathogens
researchProduct

PeptoSomes for Vaccination: Combining Antigen and Adjuvant in Polypept(o)ide-Based Polymersomes.

2017

In this work, the first vaccine is reported based on a PeptoSome, which contains a model antigen (SIINFEKL) and adjuvant (CpG). PeptoSomes are polypept(o)ide-based polymersomes built of a block-copolymer with polysarcosine (PSar) as the hydrophilic block (X n = 111) and poly(benzyl-glutamic acid) (PGlu(OBn)) as the hydrophobic one (X n = 46). The polypept(o)ide is obtained with low dispersity index of 1.32 by controlled ring-opening polymerization. Vesicle formation by dual centrifugation technique allows for loading of vesicles up to 40 mol%. PeptoSomes are characterized by multiangle dynamic light scattering, static light scattering, and cryogenic transmission electron microscopy (cryoTEM…

Hydrodynamic radiusPolymers and Plasticsmedicine.medical_treatmentT-LymphocytesDispersityGene ExpressionBioengineeringchemical and pharmacologic phenomenaBone Marrow Cells02 engineering and technology010402 general chemistryLymphocyte Activation01 natural sciencesBiomaterialsPeptoidsDynamic light scatteringAntigenAdjuvants ImmunologicMaterials ChemistrymedicineHumansStatic light scatteringAntigensVaccinesChemistryVesicleVaccinationSarcosineDendritic Cells021001 nanoscience & nanotechnologyMolecular biologyCoculture Techniques0104 chemical sciencesOligodeoxyribonucleotidesPolymersomeB7-1 AntigenCytokinesB7-2 Antigen0210 nano-technologyPeptidesAdjuvantBiomarkersBiotechnologyMacromolecular bioscience
researchProduct